Pharmafile - Sales and Marketing
Johnson & Johnson’s Imbruvica (ibrutinib) has scored its fifth indication approval in the US for the treatment of Marginal Zone Lymphoma (MZL...
Check out the Top Ten most popular articles on Pharmafile.com this week!
Jenny Tragner, director at R&D tax credit consultancy ForrestBrown and member of the UK R&D Consultative Committee discusses the importance...
Sanofi’s diabetes drug Suliqua has been granted marketing authorisation by the European Commission.
Happy New Year from us here at Pharmafocus! As we leave 2016 behind, take a look at ten of its biggest stories, according to our readers.
Service Company News